Eliquis (apixaban) is the most prescribed blood thinner in the United States and is covered by virtually all insurance plans for its approved indications (atrial fibrillation, DVT/PE treatment and prevention). As one of the highest-revenue drugs in the country, Eliquis remains a brand-name medication with no generic available yet. The Inflation Reduction Act's Medicare price negotiation may impact Eliquis pricing.

Key Facts

Eliquis is covered on nearly all commercial, Medicare, and Medicaid formularies
Typical tier placement: Tier 3 (preferred brand) on most commercial plans
Medicare Part D copay: variable, but the $2,000 annual out-of-pocket cap limits total spending
Eliquis was selected for Medicare price negotiation under the Inflation Reduction Act, with negotiated price effective 2026
BMS/Pfizer copay card reduces cost to as low as $10/month for eligible commercially insured patients
Without insurance, Eliquis costs approximately $550 to $600 per month

Open Enrollment Reminder

ACA marketplace enrollment runs November 1 to January 15. Medicare Annual Enrollment is October 15 to December 7. Compare formularies for your medications before choosing a plan.

Can't Afford Your Medication?
Find Patient Assistance Programs
Search manufacturer PAPs and nonprofit programs on OmniRx
Compare Cash Prices
Find the Lowest Pharmacy Price
Compare prices at pharmacies near you on RxGrab

Check Your Specific Plan's Formulary

Coverage varies by plan. Use our formulary checker tool to look up your exact copay and restrictions.

Open Formulary Checker

Frequently Asked Questions

Is there a generic for Eliquis in 2026?

As of 2026, there is no FDA-approved generic version of Eliquis (apixaban). Patent litigation settlements suggest generic entry may occur in the 2028 to 2031 timeframe. In the meantime, the IRA-negotiated Medicare price and manufacturer copay programs help reduce costs.

How much does Eliquis cost on Medicare?

Eliquis costs on Medicare Part D vary by plan, but the $2,000 annual out-of-pocket cap means your total drug spending is limited. Eliquis was among the first drugs selected for Medicare price negotiation under the IRA. The negotiated price, effective in 2026, should reduce overall plan costs and potentially lower beneficiary copays.

Can I get help paying for Eliquis?

Yes. BMS offers the Eliquis 360 Support program with a copay card for commercially insured patients (as low as $10/month). For uninsured or underinsured patients, the BMS Access Support program may provide Eliquis at no cost. Medicare patients cannot use manufacturer copay cards but may qualify for Extra Help (LIS).

Related Resources

Get Formulary and Coverage Updates

Subscribe to receive alerts on formulary changes, new drug approvals, and insurance coverage updates.